Imaging tests: Using them wisely
Content restricted. Requires subscription
Protein Supplements
I am a 41-year-old man who is getting back into body building and considering a protein supplement. How many grams of protein can the body digest and use at a time?
Content restricted. Requires subscription
Which foods can raise your LDL cholesterol?
Curious which foods can drive up LDL, or bad, cholesterol? Explore the role of saturated fat and how Mediterranean-style eating may protect your heart.
Content restricted. Requires subscription
Stomach Flu
What causes stomach flu and how is it transmitted?
Content restricted. Requires subscription
Teens with upbeat friends may have better emotional health
Content restricted. Requires subscription
The changing landscape of heart disease and diabetes care
About two-thirds of people with type 2 diabetes die from heart disease. But updated screening and prevention guidelines, along with a novel diabetes drug with proven heart benefits, may improve that statistic.
Content restricted. Requires subscription
The Nordic diet: A northern twist to the Mediterranean diet
The Nordic diet includes many heart-healthy foods such as whole grains, berries, and fatty fish. Limited evidence suggests this eating pattern may foster weight loss and lower blood pressure.
Content restricted. Requires subscription
How old is your heart?
An online “heart age” calculator can help people understand their risk of heart attack and stroke. The estimate is based on a person’s blood pressure reading, smoking history, body mass index, and whether they have diabetes
Content restricted. Requires subscription
Deep-vein blood clots: Know the signs
Many Americans don’t know the symptoms of a blood clot in a leg or arm (known as deep-vein thrombosis), which include pain, swelling, and redness. A blood clot in the lungs (called a pulmonary embolism) is twice as likely to be fatal as a heart attack.
Content restricted. Requires subscription
Research we’re watching: FDA approves antidote to anti-clotting drug
The FDA has approved idarucizumab (Praxbind), a drug that quickly reverses the effects of the anti-clotting medication dabigatran (Pradaxa).
Content restricted. Requires subscription